世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
ファーマコビジランス（PV）アウトソーシング - 世界市場シェアとランキング、全体売上高と需要予測 2024-2030Pharmacovigilance (PV) Outsourcing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030 ファーマコビジランス（PV）アウトソーシングの世界市場規模は、2023年に100万米ドルと推定され、2024-2030年の予測期間中の年平均成長率は%で、2030年には100万米ドルに再調整されると予測されている。 世界の... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリーファーマコビジランス（PV）アウトソーシングの世界市場規模は、2023年に100万米ドルと推定され、2024-2030年の予測期間中の年平均成長率は%で、2030年には100万米ドルに再調整されると予測されている。世界の医薬品市場は2022年に1,475億米ドルとなり、今後6年間のCAGRは5％で成長する。医薬品市場には、化学医薬品と生物学的製剤が含まれる。生物製剤は2022年に3810億米ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間＆政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要としている患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の流行はワクチン開発とサプライチェーン・マネジメントの重要性を浮き彫りにし、製薬企業が新たな公衆衛生のニーズに機敏に対応する必要性をさらに強調している。 レポートの範囲 本レポートは、ファーマコビジランス（PV）アウトソーシングの世界市場を包括的に紹介することを目的としており、地域別・国別、タイプ別、用途別のファーマコビジランス（PV）アウトソーシングの分析とともに、総売上高、主要企業の市場シェア、ランキングに焦点を当てています。 ファーマコビジランス（PV）アウトソーシングの市場規模、推計、予測は、2023年を基準年とし、2019年から2030年までの期間の履歴データと予測データを売上高（百万ドル）で提供します。定量分析および定性分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、ファーマコビジランス（PV）アウトソーシングに関する十分な情報に基づいたビジネス上の意思決定を行えるよう支援します。 市場区分 企業別 アクセンチュア C3iソリューションズ クリンテック コバンス デロイト トウシュ トーマツ リミテッド ELCグループ エルゴメド 株式会社アイゲート アイメッド・グローバル・コーポレーション IQVIA マークスマンヘルスケア メドスペース・ホールディングス ノバルティス オラクル・コーポレーション パレクセル ファームインベント プライムビジランス ピュア・ドラッグ・セーフティ サイフォミックス SIRO Clinpharm シモゲン タイプ別セグメント CRO（医薬品開発業務受託機関） ビジネス・プロセス・アウトソーシング（BPOs） アプリケーション別セグメント 市販前臨床試験 市販後臨床試験 その他 地域別 北米 米国 カナダ 欧州 ドイツ フランス 英国 イタリア ロシア アジア太平洋 中国 日本 韓国 中国 台湾 東南アジア インド ラテンアメリカ メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 各章の概要 第1章：報告書のスコープ、世界の総市場規模を紹介します。また本章では、市場ダイナミクス、市場の最新動向、市場の促進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章：ファーマコビジランス（PV）アウトソーシングメーカーの競争環境、収益市場シェア、最新の開発計画、合併・買収情報などを詳細に分析します。 第3章：各種市場セグメントをタイプ別に分析し、各市場セグメントの市場規模や発展可能性を網羅し、読者が各市場セグメントのブルーオーシャン市場を見つけやすくします。 第4章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展の可能性をカバーし、読者が異なる川下市場のブルーオーシャン市場を見つけるのに役立ちます。 第5章：地域レベルでのファーマコビジランス（PV）アウトソーシングの収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展見込み、市場スペース、市場規模を紹介しています。 第6章 ファーマコビジランス（PV）アウトソーシングの国別収益。各国/地域のタイプ別、用途別のシグメイトデータを提供。 第7章：主要企業のプロファイルを提供し、製品収益、売上総利益率、製品紹介、最近の開発など、市場における主要企業の基本的な状況を詳細に紹介します。 第8章：産業の上流と下流を含む産業チェーンの分析。 第9章：結論 目次1 Market Overview1.1 Pharmacovigilance (PV) Outsourcing Product Introduction 1.2 Global Pharmacovigilance (PV) Outsourcing Market Size Forecast 1.3 Pharmacovigilance (PV) Outsourcing Market Trends & Drivers 1.3.1 Pharmacovigilance (PV) Outsourcing Industry Trends 1.3.2 Pharmacovigilance (PV) Outsourcing Market Drivers & Opportunity 1.3.3 Pharmacovigilance (PV) Outsourcing Market Challenges 1.3.4 Pharmacovigilance (PV) Outsourcing Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Pharmacovigilance (PV) Outsourcing Players Revenue Ranking (2023) 2.2 Global Pharmacovigilance (PV) Outsourcing Revenue by Company (2019-2024) 2.3 Key Companies Pharmacovigilance (PV) Outsourcing Manufacturing Base Distribution and Headquarters 2.4 Key Companies Pharmacovigilance (PV) Outsourcing Product Offered 2.5 Key Companies Time to Begin Mass Production of Pharmacovigilance (PV) Outsourcing 2.6 Pharmacovigilance (PV) Outsourcing Market Competitive Analysis 2.6.1 Pharmacovigilance (PV) Outsourcing Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Pharmacovigilance (PV) Outsourcing Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance (PV) Outsourcing as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Contract Research Organizations (CROs) 3.1.2 Business Process Outsourcing (BPOs) 3.2 Global Pharmacovigilance (PV) Outsourcing Sales Value by Type 3.2.1 Global Pharmacovigilance (PV) Outsourcing Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Pharmacovigilance (PV) Outsourcing Sales Value, by Type (2019-2030) 3.2.3 Global Pharmacovigilance (PV) Outsourcing Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Premarketing Clinical Trial 4.1.2 Post-marketing Clinical Practice 4.1.3 Other 4.2 Global Pharmacovigilance (PV) Outsourcing Sales Value by Application 4.2.1 Global Pharmacovigilance (PV) Outsourcing Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Pharmacovigilance (PV) Outsourcing Sales Value, by Application (2019-2030) 4.2.3 Global Pharmacovigilance (PV) Outsourcing Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Pharmacovigilance (PV) Outsourcing Sales Value by Region 5.1.1 Global Pharmacovigilance (PV) Outsourcing Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Pharmacovigilance (PV) Outsourcing Sales Value by Region (2019-2024) 5.1.3 Global Pharmacovigilance (PV) Outsourcing Sales Value by Region (2025-2030) 5.1.4 Global Pharmacovigilance (PV) Outsourcing Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 5.2.2 North America Pharmacovigilance (PV) Outsourcing Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 5.3.2 Europe Pharmacovigilance (PV) Outsourcing Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 5.4.2 Asia Pacific Pharmacovigilance (PV) Outsourcing Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 5.5.2 South America Pharmacovigilance (PV) Outsourcing Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 5.6.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Pharmacovigilance (PV) Outsourcing Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Pharmacovigilance (PV) Outsourcing Sales Value 6.3 United States 6.3.1 United States Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 6.3.2 United States Pharmacovigilance (PV) Outsourcing Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Pharmacovigilance (PV) Outsourcing Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 6.4.2 Europe Pharmacovigilance (PV) Outsourcing Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Pharmacovigilance (PV) Outsourcing Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 6.5.2 China Pharmacovigilance (PV) Outsourcing Sales Value by Type (%), 2023 VS 2030 6.5.3 China Pharmacovigilance (PV) Outsourcing Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 6.6.2 Japan Pharmacovigilance (PV) Outsourcing Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Pharmacovigilance (PV) Outsourcing Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 6.7.2 South Korea Pharmacovigilance (PV) Outsourcing Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Pharmacovigilance (PV) Outsourcing Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 6.8.2 Southeast Asia Pharmacovigilance (PV) Outsourcing Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Pharmacovigilance (PV) Outsourcing Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 6.9.2 India Pharmacovigilance (PV) Outsourcing Sales Value by Type (%), 2023 VS 2030 6.9.3 India Pharmacovigilance (PV) Outsourcing Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 Accenture 7.1.1 Accenture Profile 7.1.2 Accenture Main Business 7.1.3 Accenture Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.1.4 Accenture Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.1.5 Accenture Recent Developments 7.2 C3i Solutions 7.2.1 C3i Solutions Profile 7.2.2 C3i Solutions Main Business 7.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.2.4 C3i Solutions Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.2.5 C3i Solutions Recent Developments 7.3 Clintec 7.3.1 Clintec Profile 7.3.2 Clintec Main Business 7.3.3 Clintec Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.3.4 Clintec Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.3.5 Covance Recent Developments 7.4 Covance 7.4.1 Covance Profile 7.4.2 Covance Main Business 7.4.3 Covance Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.4.4 Covance Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.4.5 Covance Recent Developments 7.5 Deloitte Touche Tohmatsu Limited 7.5.1 Deloitte Touche Tohmatsu Limited Profile 7.5.2 Deloitte Touche Tohmatsu Limited Main Business 7.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.5.4 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.5.5 Deloitte Touche Tohmatsu Limited Recent Developments 7.6 ELC Group 7.6.1 ELC Group Profile 7.6.2 ELC Group Main Business 7.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.6.4 ELC Group Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.6.5 ELC Group Recent Developments 7.7 Ergomed 7.7.1 Ergomed Profile 7.7.2 Ergomed Main Business 7.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.7.4 Ergomed Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.7.5 Ergomed Recent Developments 7.8 iGATE Corporation 7.8.1 iGATE Corporation Profile 7.8.2 iGATE Corporation Main Business 7.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.8.4 iGATE Corporation Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.8.5 iGATE Corporation Recent Developments 7.9 iMED Global Corporation 7.9.1 iMED Global Corporation Profile 7.9.2 iMED Global Corporation Main Business 7.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.9.4 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.9.5 iMED Global Corporation Recent Developments 7.10 IQVIA 7.10.1 IQVIA Profile 7.10.2 IQVIA Main Business 7.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.10.4 IQVIA Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.10.5 IQVIA Recent Developments 7.11 MarksMan Healthcare 7.11.1 MarksMan Healthcare Profile 7.11.2 MarksMan Healthcare Main Business 7.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.11.4 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.11.5 MarksMan Healthcare Recent Developments 7.12 Medpace Holdings 7.12.1 Medpace Holdings Profile 7.12.2 Medpace Holdings Main Business 7.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.12.4 Medpace Holdings Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.12.5 Medpace Holdings Recent Developments 7.13 Novartis 7.13.1 Novartis Profile 7.13.2 Novartis Main Business 7.13.3 Novartis Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.13.4 Novartis Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.13.5 Novartis Recent Developments 7.14 Oracle Corporation 7.14.1 Oracle Corporation Profile 7.14.2 Oracle Corporation Main Business 7.14.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.14.4 Oracle Corporation Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.14.5 Oracle Corporation Recent Developments 7.15 Parexel 7.15.1 Parexel Profile 7.15.2 Parexel Main Business 7.15.3 Parexel Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.15.4 Parexel Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.15.5 Parexel Recent Developments 7.16 PharmInvent 7.16.1 PharmInvent Profile 7.16.2 PharmInvent Main Business 7.16.3 PharmInvent Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.16.4 PharmInvent Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.16.5 PharmInvent Recent Developments 7.17 PrimeVigilance 7.17.1 PrimeVigilance Profile 7.17.2 PrimeVigilance Main Business 7.17.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.17.4 PrimeVigilance Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.17.5 PrimeVigilance Recent Developments 7.18 Pure Drug Safety 7.18.1 Pure Drug Safety Profile 7.18.2 Pure Drug Safety Main Business 7.18.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.18.4 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.18.5 Pure Drug Safety Recent Developments 7.19 Sciformix 7.19.1 Sciformix Profile 7.19.2 Sciformix Main Business 7.19.3 Sciformix Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.19.4 Sciformix Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.19.5 Sciformix Recent Developments 7.20 SIRO Clinpharm 7.20.1 SIRO Clinpharm Profile 7.20.2 SIRO Clinpharm Main Business 7.20.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.20.4 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.20.5 SIRO Clinpharm Recent Developments 7.21 Symogen 7.21.1 Symogen Profile 7.21.2 Symogen Main Business 7.21.3 Symogen Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.21.4 Symogen Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.21.5 Symogen Recent Developments 8 Industry Chain Analysis 8.1 Pharmacovigilance (PV) Outsourcing Industrial Chain 8.2 Pharmacovigilance (PV) Outsourcing Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Pharmacovigilance (PV) Outsourcing Sales Model 8.5.2 Sales Channel 8.5.3 Pharmacovigilance (PV) Outsourcing Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
SummaryThe global market for Pharmacovigilance (PV) Outsourcing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. Table of Contents1 Market Overview1.1 Pharmacovigilance (PV) Outsourcing Product Introduction 1.2 Global Pharmacovigilance (PV) Outsourcing Market Size Forecast 1.3 Pharmacovigilance (PV) Outsourcing Market Trends & Drivers 1.3.1 Pharmacovigilance (PV) Outsourcing Industry Trends 1.3.2 Pharmacovigilance (PV) Outsourcing Market Drivers & Opportunity 1.3.3 Pharmacovigilance (PV) Outsourcing Market Challenges 1.3.4 Pharmacovigilance (PV) Outsourcing Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Pharmacovigilance (PV) Outsourcing Players Revenue Ranking (2023) 2.2 Global Pharmacovigilance (PV) Outsourcing Revenue by Company (2019-2024) 2.3 Key Companies Pharmacovigilance (PV) Outsourcing Manufacturing Base Distribution and Headquarters 2.4 Key Companies Pharmacovigilance (PV) Outsourcing Product Offered 2.5 Key Companies Time to Begin Mass Production of Pharmacovigilance (PV) Outsourcing 2.6 Pharmacovigilance (PV) Outsourcing Market Competitive Analysis 2.6.1 Pharmacovigilance (PV) Outsourcing Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Pharmacovigilance (PV) Outsourcing Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance (PV) Outsourcing as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Contract Research Organizations (CROs) 3.1.2 Business Process Outsourcing (BPOs) 3.2 Global Pharmacovigilance (PV) Outsourcing Sales Value by Type 3.2.1 Global Pharmacovigilance (PV) Outsourcing Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Pharmacovigilance (PV) Outsourcing Sales Value, by Type (2019-2030) 3.2.3 Global Pharmacovigilance (PV) Outsourcing Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Premarketing Clinical Trial 4.1.2 Post-marketing Clinical Practice 4.1.3 Other 4.2 Global Pharmacovigilance (PV) Outsourcing Sales Value by Application 4.2.1 Global Pharmacovigilance (PV) Outsourcing Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Pharmacovigilance (PV) Outsourcing Sales Value, by Application (2019-2030) 4.2.3 Global Pharmacovigilance (PV) Outsourcing Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Pharmacovigilance (PV) Outsourcing Sales Value by Region 5.1.1 Global Pharmacovigilance (PV) Outsourcing Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Pharmacovigilance (PV) Outsourcing Sales Value by Region (2019-2024) 5.1.3 Global Pharmacovigilance (PV) Outsourcing Sales Value by Region (2025-2030) 5.1.4 Global Pharmacovigilance (PV) Outsourcing Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 5.2.2 North America Pharmacovigilance (PV) Outsourcing Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 5.3.2 Europe Pharmacovigilance (PV) Outsourcing Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 5.4.2 Asia Pacific Pharmacovigilance (PV) Outsourcing Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 5.5.2 South America Pharmacovigilance (PV) Outsourcing Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 5.6.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Pharmacovigilance (PV) Outsourcing Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Pharmacovigilance (PV) Outsourcing Sales Value 6.3 United States 6.3.1 United States Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 6.3.2 United States Pharmacovigilance (PV) Outsourcing Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Pharmacovigilance (PV) Outsourcing Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 6.4.2 Europe Pharmacovigilance (PV) Outsourcing Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Pharmacovigilance (PV) Outsourcing Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 6.5.2 China Pharmacovigilance (PV) Outsourcing Sales Value by Type (%), 2023 VS 2030 6.5.3 China Pharmacovigilance (PV) Outsourcing Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 6.6.2 Japan Pharmacovigilance (PV) Outsourcing Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Pharmacovigilance (PV) Outsourcing Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 6.7.2 South Korea Pharmacovigilance (PV) Outsourcing Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Pharmacovigilance (PV) Outsourcing Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 6.8.2 Southeast Asia Pharmacovigilance (PV) Outsourcing Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Pharmacovigilance (PV) Outsourcing Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Pharmacovigilance (PV) Outsourcing Sales Value, 2019-2030 6.9.2 India Pharmacovigilance (PV) Outsourcing Sales Value by Type (%), 2023 VS 2030 6.9.3 India Pharmacovigilance (PV) Outsourcing Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 Accenture 7.1.1 Accenture Profile 7.1.2 Accenture Main Business 7.1.3 Accenture Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.1.4 Accenture Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.1.5 Accenture Recent Developments 7.2 C3i Solutions 7.2.1 C3i Solutions Profile 7.2.2 C3i Solutions Main Business 7.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.2.4 C3i Solutions Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.2.5 C3i Solutions Recent Developments 7.3 Clintec 7.3.1 Clintec Profile 7.3.2 Clintec Main Business 7.3.3 Clintec Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.3.4 Clintec Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.3.5 Covance Recent Developments 7.4 Covance 7.4.1 Covance Profile 7.4.2 Covance Main Business 7.4.3 Covance Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.4.4 Covance Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.4.5 Covance Recent Developments 7.5 Deloitte Touche Tohmatsu Limited 7.5.1 Deloitte Touche Tohmatsu Limited Profile 7.5.2 Deloitte Touche Tohmatsu Limited Main Business 7.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.5.4 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.5.5 Deloitte Touche Tohmatsu Limited Recent Developments 7.6 ELC Group 7.6.1 ELC Group Profile 7.6.2 ELC Group Main Business 7.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.6.4 ELC Group Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.6.5 ELC Group Recent Developments 7.7 Ergomed 7.7.1 Ergomed Profile 7.7.2 Ergomed Main Business 7.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.7.4 Ergomed Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.7.5 Ergomed Recent Developments 7.8 iGATE Corporation 7.8.1 iGATE Corporation Profile 7.8.2 iGATE Corporation Main Business 7.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.8.4 iGATE Corporation Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.8.5 iGATE Corporation Recent Developments 7.9 iMED Global Corporation 7.9.1 iMED Global Corporation Profile 7.9.2 iMED Global Corporation Main Business 7.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.9.4 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.9.5 iMED Global Corporation Recent Developments 7.10 IQVIA 7.10.1 IQVIA Profile 7.10.2 IQVIA Main Business 7.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.10.4 IQVIA Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.10.5 IQVIA Recent Developments 7.11 MarksMan Healthcare 7.11.1 MarksMan Healthcare Profile 7.11.2 MarksMan Healthcare Main Business 7.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.11.4 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.11.5 MarksMan Healthcare Recent Developments 7.12 Medpace Holdings 7.12.1 Medpace Holdings Profile 7.12.2 Medpace Holdings Main Business 7.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.12.4 Medpace Holdings Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.12.5 Medpace Holdings Recent Developments 7.13 Novartis 7.13.1 Novartis Profile 7.13.2 Novartis Main Business 7.13.3 Novartis Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.13.4 Novartis Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.13.5 Novartis Recent Developments 7.14 Oracle Corporation 7.14.1 Oracle Corporation Profile 7.14.2 Oracle Corporation Main Business 7.14.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.14.4 Oracle Corporation Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.14.5 Oracle Corporation Recent Developments 7.15 Parexel 7.15.1 Parexel Profile 7.15.2 Parexel Main Business 7.15.3 Parexel Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.15.4 Parexel Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.15.5 Parexel Recent Developments 7.16 PharmInvent 7.16.1 PharmInvent Profile 7.16.2 PharmInvent Main Business 7.16.3 PharmInvent Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.16.4 PharmInvent Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.16.5 PharmInvent Recent Developments 7.17 PrimeVigilance 7.17.1 PrimeVigilance Profile 7.17.2 PrimeVigilance Main Business 7.17.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.17.4 PrimeVigilance Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.17.5 PrimeVigilance Recent Developments 7.18 Pure Drug Safety 7.18.1 Pure Drug Safety Profile 7.18.2 Pure Drug Safety Main Business 7.18.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.18.4 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.18.5 Pure Drug Safety Recent Developments 7.19 Sciformix 7.19.1 Sciformix Profile 7.19.2 Sciformix Main Business 7.19.3 Sciformix Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.19.4 Sciformix Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.19.5 Sciformix Recent Developments 7.20 SIRO Clinpharm 7.20.1 SIRO Clinpharm Profile 7.20.2 SIRO Clinpharm Main Business 7.20.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.20.4 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.20.5 SIRO Clinpharm Recent Developments 7.21 Symogen 7.21.1 Symogen Profile 7.21.2 Symogen Main Business 7.21.3 Symogen Pharmacovigilance (PV) Outsourcing Products, Services and Solutions 7.21.4 Symogen Pharmacovigilance (PV) Outsourcing Revenue (US$ Million) & (2019-2024) 7.21.5 Symogen Recent Developments 8 Industry Chain Analysis 8.1 Pharmacovigilance (PV) Outsourcing Industrial Chain 8.2 Pharmacovigilance (PV) Outsourcing Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Pharmacovigilance (PV) Outsourcing Sales Model 8.5.2 Sales Channel 8.5.3 Pharmacovigilance (PV) Outsourcing Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート本レポートと同じKEY WORD（）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|